{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:25:13Z","timestamp":1774070713821,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,28]],"date-time":"2027-01-28T00:00:00Z","timestamp":1801094400000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001297","name":"Elisabeth Severance Prentiss Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004528"],"award-info":[{"award-number":["UM1TR004528"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jocn.2026.111896","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:20:54Z","timestamp":1769620854000},"page":"111896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparative safety and health service utilization for gabapentin versus non-steroidal anti-inflammatory drugs for cervical radiculopathy: A retrospective cohort study of academic centers"],"prefix":"10.1016","volume":"146","author":[{"given":"Anthony N.","family":"Baumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Trager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalton","family":"McGlamery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahabeddin","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keegan T.","family":"Conry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Preston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob C.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.111896_b0005","first-page":"58","article-title":"Therapeutic drug monitoring of gabapentin: the applicability in patients with neuropathic pain","author":"Yamamoto","year":"2022","journal-title":"Braz J Pharm Sci"},{"issue":"6","key":"10.1016\/j.jocn.2026.111896_b0010","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/aem316","article-title":"A multimodal perioperative drug?","volume":"99","author":"Kong","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jocn.2026.111896_b0015","article-title":"Gabapentin for Off-Label Use: Evidence-based or Cause for concern?","volume":"12","author":"Peckham","year":"2018","journal-title":"Subst Abuse"},{"issue":"3","key":"10.1016\/j.jocn.2026.111896_b0020","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-013-0057-y","article-title":"Implications and mechanism of action of gabapentin in neuropathic pain","volume":"36","author":"Kukkar","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jocn.2026.111896_b0025","article-title":"On Patient Safety: it is Time to Rethink Gabapentin","author":"Rickert","year":"2025","journal-title":"Clin Orthop Relat Res Published online"},{"key":"10.1016\/j.jocn.2026.111896_b0030","doi-asserted-by":"crossref","unstructured":"Barton C, Kalakoti P, Bedard NA, Hendrickson NR, Saifi C, Pugely AJ. What Are the Costs of Cervical Radiculopathy Prior to Surgical Treatment. In: Spine. Vol 44. ; 2019. doi:10.1097\/BRS.0000000000002983.","DOI":"10.1097\/BRS.0000000000002983"},{"issue":"1","key":"10.1016\/j.jocn.2026.111896_b0035","doi-asserted-by":"crossref","DOI":"10.18203\/2319-2003.ijbcp20205540","article-title":"Comparative study of safety and efficacy of pregabalin, gabapentin and amitriptyline in management of neuropathic pain","volume":"10","author":"Kancherla","year":"2020","journal-title":"Int J Basic Clin Pharmacol"},{"key":"10.1016\/j.jocn.2026.111896_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4905013","article-title":"Gabapentin versus transdermal fentanyl matrix for the alleviation of chronic neuropathic pain of radicular origin: a randomized blind multicentered parallel-group noninferiority trial","author":"Hwang","year":"2019","journal-title":"Pain Res Manag"},{"issue":"11","key":"10.1016\/j.jocn.2026.111896_b0045","doi-asserted-by":"crossref","DOI":"10.18203\/2319-2003.ijbcp20194788","article-title":"Comparative study of safety and efficacy of pregabalin and gabapentin in management of neuropathic pain associated with chronic lumbar radiculopathy","volume":"8","author":"Shaikh","year":"2019","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jocn.2026.111896_b0050","volume":"9","author":"Huzaif","year":"2022","journal-title":"Comparative Study of Efficacy and Safety of Gabapentin and Amitriptyline in Treatment of Neuropathic Pain Associated with Chronic Lumbar Radiculopathy An Open Label, Prospective Randomized Clinical Study European journal of molecular and clinical medicine"},{"issue":"12","key":"10.1016\/j.jocn.2026.111896_b0055","doi-asserted-by":"crossref","DOI":"10.2176\/nmc.50.1070","article-title":"Efficacy of gabapentin for radiculopathy caused by lumbar spinal stenosis and lumbar disk hernia","volume":"50","author":"Kasimcan","year":"2010","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"32","key":"10.1016\/j.jocn.2026.111896_b0060","article-title":"Comparing the therapeutic effects of pregabalin and gabapentin after transforaminal epidural nerve block in lumbar radiculopathy","volume":"101","author":"Kwon","year":"2022","journal-title":"Medicine (United States)"},{"issue":"11","key":"10.1016\/j.jocn.2026.111896_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00586-018-5777-8","article-title":"Clinical course and prognostic models for the conservative management of cervical radiculopathy: a prospective cohort study","volume":"27","author":"Sleijser-Koehorst","year":"2018","journal-title":"Eur Spine J"},{"issue":"9","key":"10.1016\/j.jocn.2026.111896_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s00586-017-5121-8","article-title":"National clinical guidelines for non-surgical treatment of patients with recent onset neck pain or cervical radiculopathy","volume":"26","author":"Kjaer","year":"2017","journal-title":"Eur Spine J"},{"issue":"1","key":"10.1016\/j.jocn.2026.111896_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.spinee.2010.10.023","article-title":"An evidence-based clinical guideline for the diagnosis and treatment of cervical radiculopathy from degenerative disorders","volume":"11","author":"Bono","year":"2011","journal-title":"Spine Journal"},{"issue":"5","key":"10.1016\/j.jocn.2026.111896_b0080","article-title":"A Clinical Overview of Off-label use of Gabapentinoid Drugs. JAMA","volume":"179","author":"Goodman","year":"2019","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.jocn.2026.111896_b0085","doi-asserted-by":"crossref","DOI":"10.4997\/jrcpe.2017.402","article-title":"Gabapentin and pregabalin: do the benefits outweigh the harms?","volume":"47","author":"Morrison","year":"2017","journal-title":"Journal of the Royal College of Physicians of Edinburgh"},{"issue":"5","key":"10.1016\/j.jocn.2026.111896_b0090","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and Pregabalin for Pain \u2014 is increased Prescribing a Cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jocn.2026.111896_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010083","article-title":"Trends, patient and prescriber characteristics in gabapentinoid use in a sample of United States ambulatory care visits","volume":"9","author":"Zhou","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jocn.2026.111896_b0100","doi-asserted-by":"crossref","unstructured":"Costales B, Brown JD, Goodin AJ. PDG46 OUTPATIENT OFF-LABEL GABAPENTIN UTILIZATION FROM 2011 TO 2015 AMONG UNITED STATES ADULTS. Value in Health. 2020;23. doi:10.1016\/j.jval.2020.04.334.","DOI":"10.1016\/j.jval.2020.04.334"},{"issue":"5","key":"10.1016\/j.jocn.2026.111896_b0105","doi-asserted-by":"crossref","DOI":"10.1097\/ALN.0000000000000409","article-title":"Epidural steroid injections, conservative treatment, or combination treatment for cervical radicular pain: a multicenter, randomized, comparative-effectiveness study","volume":"121","author":"Cohen","year":"2014","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.jocn.2026.111896_b0110","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-012-0006-6","article-title":"Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database","volume":"36","author":"Fuzier","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.jocn.2026.111896_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1009950","article-title":"Risk of major adverse events associated with gabapentinoid and opioid combination therapy: a systematic review and meta-analysis","volume":"13","author":"Hahn","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.jocn.2026.111896_b0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.31647","article-title":"Association of Gabapentinoids with the risk of Opioid-Related adverse events in Surgical patients in the United States","volume":"3","author":"Bykov","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jocn.2026.111896_b0125","doi-asserted-by":"crossref","unstructured":"Gold LS, Heagerty PJ, Hansen RN, et al. Adverse respiratory events during treatment with gabapentin and opioids among older adults with spine-related conditions: a propensity-matched cohort study in the US Medicare population. The Spine Journal. Published online March 20doi:10.1016\/j.spinee.2025.03.014.","DOI":"10.1016\/j.spinee.2025.03.014"},{"issue":"2","key":"10.1016\/j.jocn.2026.111896_b0130","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-017-0595-1","article-title":"All-Cause and Drug-Related Medical events Associated with Overuse of Gabapentin and\/or Opioid Medications: a Retrospective Cohort Analysis of a Commercially Insured US Population","volume":"41","author":"Peckham","year":"2018","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.jocn.2026.111896_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-019-05549-8","article-title":"Patterns of Opioid and Benzodiazepine Use in Opioid-Na\u00efve patients with newly Diagnosed Low Back and lower Extremity Pain","volume":"35","author":"Azad","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.jocn.2026.111896_b0140","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.21897","article-title":"off-label use, and lessons for postmarketing evaluation efforts. JAMA -","volume":"319","author":"Wallach","year":"2018","journal-title":"J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.jocn.2026.111896_b0145","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-016-0584-1","article-title":"Enacarbil:A Review in Restless Legs Syndrome","volume":"76","author":"Kim","year":"2016","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.jocn.2026.111896_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073258","article-title":"Association between chiropractic spinal manipulation and gabapentin prescription in adults with radicular low back pain: Retrospective cohort study using US data","volume":"13","author":"Trager","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jocn.2026.111896_b0155","doi-asserted-by":"crossref","DOI":"10.2147\/JEP.S124391","article-title":"Review about gabapentin misuse, interactions, contraindications and side effects","volume":"9","author":"Quintero","year":"2017","journal-title":"J Exp Pharmacol"},{"key":"10.1016\/j.jocn.2026.111896_b0160","first-page":"58","article-title":"The effects of exercise therapy on adolescent idiopathic scoliosis: an overview of systematic reviews and meta-analyses","author":"Zhou","year":"2021","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.jocn.2026.111896_b0165","doi-asserted-by":"crossref","DOI":"10.2147\/JPR.S345521","article-title":"Geographic Variation in the use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States","volume":"15","author":"Zhao","year":"2022","journal-title":"J Pain Res"},{"issue":"6","key":"10.1016\/j.jocn.2026.111896_b0170","article-title":"Perioperative Factors Associated with Chronic Opioid Use after Spine Surgery. Global","volume":"13","author":"Montgomery","year":"2023","journal-title":"Spine J"},{"key":"10.1016\/j.jocn.2026.111896_b0175","article-title":"Baseline Risk Factors for Prolonged Opioid Use following Spine Surgery","volume":"159","author":"Mohan","year":"2022","journal-title":"Systematic Review and Meta-Analysis World Neurosurg"},{"issue":"3","key":"10.1016\/j.jocn.2026.111896_b0180","article-title":"Risk Factors for Prolonged Opioid Use after Spine Surgery. Global","volume":"13","author":"Kowalski","year":"2023","journal-title":"Spine J"},{"key":"10.1016\/j.jocn.2026.111896_b0185","doi-asserted-by":"crossref","unstructured":"Pauly NJ, Delcher C, Slavova S, Lindahl E, Talbert J, Freeman PR. Trends in gabapentin prescribing in a commercially insured U.S. Adult population, 2009-2016. J Manag Care Spec Pharm. 2020;26(3). doi:10.18553\/jmcp.2020.26.3.246.","DOI":"10.18553\/jmcp.2020.26.3.246"},{"issue":"4","key":"10.1016\/j.jocn.2026.111896_b0190","article-title":"Predictors of Gabapentin Overuse with or without Concomitant Opioids in a Commercially Insured U.S","volume":"38","author":"Peckham","year":"2018","journal-title":"Population Pharmacotherapy"},{"key":"10.1016\/j.jocn.2026.111896_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2020.06.081","article-title":"Long-Term Opioid Prescriptions after Spine Surgery: a Meta-Analysis of Prevalence and Risk Factors","volume":"141","author":"Lo","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2026.111896_b0200","article-title":"R Statistics: survey and review of packages for the estimation of Rasch models. Int","volume":"13","author":"Linacre","year":"2022","journal-title":"J Med Educ"},{"issue":"2","key":"10.1016\/j.jocn.2026.111896_b0205","article-title":"ggplot2. Wiley Interdiscip Rev","volume":"3","author":"Wickham","year":"2011","journal-title":"Comput Stat"},{"issue":"6","key":"10.1016\/j.jocn.2026.111896_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5623","article-title":"Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: a narrative review","volume":"32","author":"Levintow","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.jocn.2026.111896_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case\u2013control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.jocn.2026.111896_b0220","doi-asserted-by":"crossref","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022;71(3). doi:10.15585\/mmwr.rr7103a1.","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"10.1016\/j.jocn.2026.111896_b0225","first-page":"63","article-title":"Changes in orthopaedic prescribing patterns of gabapentin associated with state prescribing restrictions: a large database study","author":"Guyler","year":"2025","journal-title":"J Clin Orthop Trauma"},{"issue":"4","key":"10.1016\/j.jocn.2026.111896_b0230","doi-asserted-by":"crossref","DOI":"10.1080\/08897077.2021.1891602","article-title":"Assessment of gabapentin misuse using prescription drug monitoring program data","volume":"42","author":"Zhang","year":"2021","journal-title":"Subst Abus"},{"issue":"14","key":"10.1016\/j.jocn.2026.111896_b0235","doi-asserted-by":"crossref","DOI":"10.1080\/03610926.2015.1134575","article-title":"Relative effect sizes for measures of risk","volume":"46","author":"Olivier","year":"2017","journal-title":"Commun Stat Theory Methods"},{"issue":"12","key":"10.1016\/j.jocn.2026.111896_b0240","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jocn.2026.111896_b0245","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12178-016-9349-4","article-title":"Cervical radiculopathy","volume":"9","author":"Iyer","year":"2016","journal-title":"Curr Rev Musculoskelet Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:58:25Z","timestamp":1770695905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"alternative-id":["S0967586826000470"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111896","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative safety and health service utilization for gabapentin versus non-steroidal anti-inflammatory drugs for cervical radiculopathy: A retrospective cohort study of academic centers","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111896"}}